Literature DB >> 27157247

Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.

Kyle Spradling1, Yair Lotan2, Ahmed Shokeir3, Hassan Abol-Enein3, Ahmed Mosbah3, Jacob B Morgan1, Mohamed Ghoneim3, Ramy F Youssef4.   

Abstract

OBJECTIVE: To evaluate the association of lymphovascular invasion (LVI) with oncologic outcomes of squamous cell carcinoma (SCC) of the urinary bladder following radical cystectomy (RC). PATIENTS AND METHODS: We performed a retrospective analysis of 1,280 patients who underwent RC for invasive bladder cancer between 1997 and 2003 in Mansoura, Egypt. Only patients with pure urothelial carcinoma of the bladder (UCB) or SCC pathology were included. Using multivariate Cox regression analyses and Kaplan-Meier analyses, prognostic significance of LVI in disease-free survival and cancer-specific survival was evaluated for patients with UCB and SCC.
RESULTS: Our cohort included 519 (59%) patients with UCB and 360 (41%) with SCC. Median patient age and follow-up were 55 years (20-87) and 64 months (0-128), respectively. Median number of lymph nodes (LN) retrieved was 19 (4-70). LVI was present in 288 (32.8%) patients (241 [46.4%] UCB vs. 47 [13.1%] SCC; P<0.001). LVI was an independent predictor of oncologic outcomes in both UCB and SCC groups; however, LVI had more prognostic significance in SCC. LN negative, LVI positive (LVI+/LN-) patients with SCC had higher risk of recurrence and cancer-specific mortality compared to LN positive, LVI negative (LVI-/LN+) patients with SCC (hazard ratio = 2.8 vs. 1.9 and hazard ratio = 3.6 vs. 2.2, respectively).
CONCLUSION: The presence of LVI is an independent predictor of poor oncologic outcomes after RC and had greater prognostic significance in patients with SCC compared to UCB.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Lymphovascular invasion; Squamous cell carcinoma; Urothelial carcinoma

Mesh:

Year:  2016        PMID: 27157247     DOI: 10.1016/j.urolonc.2016.03.023

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.

Authors:  Jeremy W Martin; Simone L Vernez; Yair Lotan; Ahmed Abdelhalim; Rahul Dutta; Ahmed Shokeir; Hassan Abol-Enein; Ahmed Mosbah; Mohamed Ghoneim; Ramy F Youssef
Journal:  World J Urol       Date:  2018-05-14       Impact factor: 4.226

2.  Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma.

Authors:  Zhenhua Liu; Yisen Meng; Yudong Cao; Yuke Chen; Yu Fan; Shaobo Li; Qun He; Shiliang Wu; Wei Yu; Jie Jin
Journal:  Transl Androl Urol       Date:  2020-04

3.  Nomograms to predict individual prognosis of patients with squamous cell carcinoma of the urinary bladder.

Authors:  Guanghao Zhang; Zhiwei Li; Daoqing Song; Zhiqing Fang
Journal:  BMC Cancer       Date:  2019-12-09       Impact factor: 4.430

4.  Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma.

Authors:  Zijian Tian; Lingfeng Meng; Xin Wang; Tongxiang Diao; Maolin Hu; Miao Wang; Ming Liu; Jianye Wang
Journal:  BMC Cancer       Date:  2020-09-04       Impact factor: 4.430

5.  Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.

Authors:  Esmail M Al-Ezzi; Zachary W Veitch; Samer H Salah; Theodorus H Van der Kwast; Tracy L Stockley; Shamini Selvarajah; Tong Zhang; Srikala S Sridhar; Adrian G Sacher; Nazanin Fallah-Rad; Girish S Kulkarni; Alexandre R Zlotta; Antonio Finelli; Aaron R Hansen
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

6.  Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer.

Authors:  Zijian Tian; Lingfeng Meng; Xin Wang; Tongxiang Diao; Maolin Hu; Miao Wang; Yaqun Zhang; Ming Liu
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.